% | $
Quotes you view appear here for quick access.

Response Genetics, Inc Message Board

  • frankfrazzano frankfrazzano Oct 3, 2011 7:05 AM Flag

    RGDX....this says it all to me!

    Company Details
    Total Shares Out Standing (millions): 20
    Market Capitalization ($ millions): $37
    Institutional Ownership: 42.8%
    Price (as of 9/30/2011) 1.9

    Ownership Analysis # Of Holders Shares
    Total Shares Held: 9 8,359,549
    New Positions: 2 20,645
    Increased Positions: 4 770,157
    Decreased Positions: 2 25,757
    Holders With Activity: 6 795,914
    Sold Out Positions: 0 0
    Click on the column header links to resort ascending (ar_bk_up.gif (64 bytes)) or descending (ar_bk_dn.gif (64 bytes)).

    Owner Name
    Select a name below for more information. Date Shares Held Change
    (Shares) % Change
    (Shares) Value
    LANSDOWNE PARTNERS L... 6/30/2011 3,905,676 247,000 6.75% $7,421
    MARXE AUSTIN W & GRE... 6/30/2011 3,324,424 (25,750) (0.77%) $6,316
    PERCEPTIVE ADVISORS ... 6/30/2011 907,512 502,512 124.08% $1,724
    GEDULD E E 6/30/2011 94,300 0 0.00% $179
    FIRST MANHATTAN CO 6/30/2011 90,496 0 0.00% $172

    1 2 Next
    Page 1 of 2

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Frank...are you trying to add down here? No one is letting go of their shares!

      I just wonder where revenue will come in at for Q3. We'll be ok in the $7.5M-$8.0M range and that should also make us profitable.

      It would be nice if they would come out before earnings and announce record revenue....but now I'm dreaming....LOL.

      Also, they have been mum on a new CEO. I still think there is a possibility that they're shopping the Company.

      What do you think?


      • 2 Replies to paradise.1933
      • para, others yes to several could be the BoD is shopping the co. LT but interim CEO Mc Narin must be replaced now, that will be a must, and I too think the founder KD had many loyalists and turnover sometimes like this portends BIG internal changes coming.

        I always felt CM was brought in to RUN THE SHIP inside w/ all this change--you know what I mean keep up the momo w/ the sales force, all the internals in the lab, new layers of ability, smooth the transition...

        ...if U think U R next to be ousted you just put out feelers and jump ship on your terms rather that wait for the pink this business thats very prominent...NO real loyalty in Dx these days!

        That being said, all the fundamentals seem in place to me, and CM is very experienced w/ Roche Dx background btw, and like U say they are adding new tests...Melanoma w/ Ipi(BMY) approved now is I think rather important...

        <New ResponseDX(TM) Test Panel Launched - In June 2011, Response Genetics announced the nation-wide availability of its newest test panel, ResponseDX: Melanoma(TM), a proprietary, PCR-based diagnostic test that quantitatively analyzes mutations in the BRAF gene - a key component in cell signaling and growth. Such information can help physicians make treatment decisions for patients with this aggressive form of skin cancer. > Reps had this new Melanoma test in the bag for all of Q-3 and what it contributes is any ones guess? I must say Melanoma is quite prevalent on the west coast w/ all the surfing so it could be a real +, I only know that when I called on docs, when I had something NEW and Important they said, ""Come in lets talk!""

        This test is a door opener imo!

        ...access is key in any business!

        ...the UNCERTAINTY of all these changes is creating investor risk, and so I try to buy down here...its just that plain and simple to me para...

        holding 33K at net 1.1687


      • Just another note on revenue, they started selling the Response DX: Melanoma test at the beginning of Q3 so this should help us reach the $7.5 - $8.0 in revenue.

0.0250.0000(0.00%)Aug 10 3:59 PMEDT